跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
令泽舒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Linaclotide Capsules
Approved
化学药品
Linaclotide Capsules
AstraZeneca AG
🇨🇳 National Medical Products Administration
Approval Date
Oct 16, 2023
Approval ID
8VIZ2d29Tdu
Company
AstraZeneca AG
Type
化学药品
Approval Details
Approval Id
8VIZ2d29Tdu
Approval Number
国药准字HJ20190001
Generic Name
利那洛肽胶囊
Generic Name En
Linaclotide Capsules
Trade Name
令泽舒
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
290μg
Reg Date
2023-10-16
Expired Date
2028-10-15
Company Name
AstraZeneca AG
Production Company Name
ALMAC PHARMA SERVICES LIMITED
Company Detail Path
/organization/astrazeneca-ag
Production Company Detail Path
/organization/almac-pharma-services-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 16, 2023
Approval ID
8VIZ2d29Tdu
Type
化学药品
Back to NMPA Approvals